Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation-Reference-Cited by-同舟云学术

Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation

Published:1989-09 Issue:3 Volume:87 Page:285-288
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Vose Julie M.,Armitage James O.,Bierman Philip J.,Weisenburger Dennis D.,Hutchins Mark,Dowling Monroe D.,Moravec Daniel F.,Sorensen Scot,Okerbloom John,Bascom George,Howe David,Johnson P. Steven,Langdon Robert M.,Mailliard James,Pevnick Warren,Westberg Mark,Kessinger Anne

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Cytarabine, cisplatin and etoposide chemotherapy for refractory non-Hodgkin's lymphoma;O'Donnell;Cancer Treat Rep,1987

2. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy;Cabanillas;Blood,1982

3. Etoposide, carmustine, bleomycin and methotrexate with leucovorin rescue as retreatment for unfavorable non-Hodgkin's lymphoma;Helm;Cancer Treat Rep,1985

4. Results of MIME salvage regimen for recurrent or refractory lymphoma;Cabanillas;J Clin Oncol,1987

5. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP);Velasquez;Blood,1988

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2020-02

2. Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times–Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2016-09

3. Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma;Bone Marrow Transplantation;2007-09-10

4. IMVP-16 followed by high dose chemotherapy and autologous bone marrow transplantation as salvage treatment for malignant lymphoma;Hematological Oncology;2006-07

5. Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis;European Journal of Haematology;2003-12-22